Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 17

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Cefazolin Loaded Oxidized Regenerated Cellulose/Polycaprolactone Bilayered Composite for Use as Potential Antibacterial Dural Substitute

Sanpakitwattana, Arunnee, Suvannapruk, Waraporn, Chumnanvej, Sorayouth, Hemstapat, Ruedee, Suwanprateeb, Jintamai · 2022 · Polymers

Abstract

Oxidized regenerated cellulose/polycaprolactone bilayered composite (ORC/PCL bilayered composite) was investigated for use as an antibacterial dural substitute. Cefazolin at the concentrations of 25, 50, 75 and 100 mg/mL was loaded in the ORC/PCL bilayered composite. Microstructure, density, thickness, tensile properties, cefazolin loading content, cefazolin releasing profile and antibacterial activity against S. aureus were measured. It was seen that the change in concentration of cefazolin loading affected the microstructure of the composite on the rough side, but not on the dense or smooth side. Cefazolin loaded ORC/PCL bilayered composite showed greater densities, but lower thickness, compared to those of drug unloaded composite. Tensile modulus was found to be greater and increased with increasing cefazolin loading, but tensile strength and strain at break were lower compared to the drug unloaded composite. In vitro cefazolin release in artificial cerebrospinal fluid (aCSF) consisted of initial burst release on day 1, followed by a constant small release of cefazolin. The antibacterial activity was observed to last for up to 4 days depending on the cefazolin loading. All these results suggested that ORC/PCL bilayered composite could be modified to serve as an antibiotic carrier for potential use as an antibacterial synthetic dura mater.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/polym14204449

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 49

  1. Wang, 2019, Research and application progress on dural substitutes, J. Neurorestoratol., 7, 161, 10.26599/JNR.2019.9040020 · DOI
  2. Choi, 2021, Effectiveness of repair techniques for spinal dural tears: A systematic review, World Neurosurg., 149, 140, 10.1016/j.wneu.2021.02.079 · doi:10.1016/j.wneu.2021.02.079
  3. Suwanprateeb, 2016, Bilayer oxidized regenerated cellulose/poly ε-caprolactone knitted fabric-reinforced composite for use as an artificial dural substitute, J. Mater. Sci. Mater. Med., 27, 122, 10.1007/s10856-016-5736-z · DOI
  4. Hemstapat, 2020, Performance evaluation of bilayer oxidized regenerated cellulose/poly ε-caprolactone knitted fabric reinforced composites for dural substitution, Proc. Inst. Mech. Eng. Part H J. Eng. Med., 234, 854, 10.1177/0954411920926071 · doi:10.1177/0954411920926071
  5. Chumnanvej, 2020, In vivo evaluation of bilayer ORC/PCL composites in a rabbit model for using as a dural substitute, Neurol. Res., 42, 879, 10.1080/01616412.2020.1789383 · DOI
  6. Dwivedi, 2020, Polycaprolactone as biomaterial for bone scaffolds: Review of literature, J. Oral Biol. Craniofac. Res., 10, 381, 10.1016/j.jobcr.2019.10.003 · DOI · Paper page
  7. Backes, 2022, Polycaprolactone usage in additive manufacturing strategies for tissue engineering applications: A review, J. Biomed. Mater. Res. B Appl. Biomater., 110, 1479, 10.1002/jbm.b.34997 · DOI
  8. Kleine, J., Leisz, S., Ghadban, C., Hohmann, T., Prell, J., Scheller, C., Strauss, C., Simmermacher, S., and Dehghani, F. (2021). Variants of oxidized regenerated cellulose and their distinct effects on neuronal tissue. Int. J. Mol. Sci., 22. · DOI
  9. Bassetti, 2015, Antimicrobial prophylaxis in minor and major surgery, Minerva Anestesiol., 81, 76
  10. Erman, 2005, Risk factors for surgical site infections in neurosurgery patients with antibiotic prophylaxis, Surg. Neurol., 63, 107, 10.1016/j.surneu.2004.04.024 · DOI
  11. Bratzler, 2013, Clinical practice guidelines for antimicrobial prophylaxis in surgery, Am. J. Health Syst. Pharm., 70, 195, 10.2146/ajhp120568 · DOI · Paper page
  12. Liu, 2014, Antibiotic prophylaxis in craniotomy: A review, Neurosurg. Rev., 37, 407, 10.1007/s10143-014-0524-z · doi:10.1007/s10143-014-0524-z
  13. Gyssens, 1999, Preventing postoperative infections: Current treatment recommendations, Drugs, 57, 175, 10.2165/00003495-199957020-00004 · doi:10.2165/00003495-199957020-00004
  14. Brocard, 2021, Antibiotic prophylaxis for surgical procedures: A scoping review, Rev. Panam. Salud. Publica, 45, e62, 10.26633/RPSP.2021.62 · DOI
  15. Kusaba, 2009, Safety and efficacy of cefazolin sodium in the management of bacterial infection and in surgical prophylaxis, Clin. Med. Ther., 1, 1607
  16. Wassif, 2021, Recent advances in the local antibiotics delivery systems for management of osteomyelitis, Drug Deliv., 28, 2392, 10.1080/10717544.2021.1998246 · DOI
  17. Stebbins, 2014, Antibiotic-containing polymers for localized, sustained drug delivery, Adv. Drug Deliv. Rev., 78, 77, 10.1016/j.addr.2014.04.006 · DOI
  18. Mutsuzaki, 2014, Cefazolin-containing poly(ε-caprolactone) sponge pad to reduce pin tract infection rate in rabbits. Asia-Pac, J. Sports Med. Arthrosc. Rehabil. Technol., 1, 54
  19. Radisavljevic, 2018, Cefazolin-loaded polycaprolactone fibers produced via different electrospinning methods: Characterization, drug release and antibacterial effect, Eur. J. Pharm. Sci., 124, 26, 10.1016/j.ejps.2018.08.023 · DOI
  20. Lee, J.H., Park, J.K., Son, K.H., and Lee, J.W. (2022). PCL/sodium-alginate based 3D-printed dual drug delivery system with antibacterial activity for osteomyelitis therapy. Gels, 8. · doi:10.3390/gels8030163
  21. Yazdi, 2014, Cefazolin-loaded mesoporous silicon microparticles show sustained bactericidal effect against Staphylococcus aureus, J. Tissue Eng., 5, 2041731414536573, 10.1177/2041731414536573 · DOI
  22. Munir, 2019, Controllably biodegradable hydroxyapatite nanostructures for cefazolin delivery against antibacterial aesistance, ACS Omega, 4, 7524, 10.1021/acsomega.9b00541 · DOI
  23. Rath, 2016, Fabrication and characterization of cefazolin-loaded nanofibrous mats for the recovery of post-surgical wound, Artif. Cells Nanomed. Biotechnol., 44, 1783, 10.3109/21691401.2015.1102741 · doi:10.3109/21691401.2015.1102741
  24. Rath, 2016, Development and characterization of cefazolin loaded zinc oxide nanoparticles composite gelatin nanofiber mats for postoperative surgical wounds, Mater. Sci. Eng. C, 58, 242, 10.1016/j.msec.2015.08.050 · DOI
  25. Wang, 2013, Preliminary exploration of the development of a collagenous artificial dura mater for sustained antibiotic release, Chin. Med. J., 126, 3329, 10.3760/cma.j.issn.0366-6999.20130618 · doi:10.3760/cma.j.issn.0366-6999.20130618
  26. Kaplan, 2011, Use of antibiotic-impregnated DuraGen ® to reduce the risk of infection in dura repair: An in vitro study, Cen. Eur. Neurosurg., 72, 75, 10.1055/s-0030-1267246 · doi:10.1055/s-0030-1267246
  27. Suwanprateeb, 2014, Preparation and characterizations of antibiotic impregnated microporous nano-hydroxyapatite for osteomyelitis treatment, Biomed. Eng. Appl. Basis Commun., 26, 1450041, 10.4015/S1016237214500410 · doi:10.4015/s1016237214500410
  28. Guillen, 2011, Preparation and characterization of membranes formed by nonsolvent induced phase separation: A review, Ind. Eng. Chem. Res., 50, 3798, 10.1021/ie101928r · DOI · Paper page
  29. Tan, X.M., and Rodrigue, D. (2019). A review on porous polymeric membrane preparation. Part I: Production techniques with polysulfone and poly (vinylidene fluoride). Polymers, 11. · doi:10.3390/polym11071160
  30. Dijkstra, 1996, Phase separation processes in polymer solutions in relation to membrane formation, J. Membr. Sci., 117, 1, 10.1016/0376-7388(96)00088-9 · DOI · Paper page
  31. Bashkatov, 2003, Glucose and mannitol diffusion in human dura mater, Biophys. J., 85, 3310, 10.1016/S0006-3495(03)74750-X · DOI · Paper page
  32. Black, 1981, A study of the uniaxial mechanical properties of human dura mater preserved in glycerol, Biomaterials, 2, 41, 10.1016/0142-9612(81)90086-7 · DOI
  33. Opálková Šišková, A., Bucková, M., Kroneková, Z., Kleinová, A., Nagy, Š., Rydz, J., Opálek, A., Sláviková, M., and Eckstein Andicsová, A. (2021). The drug-loaded electrospun poly(ε-caprolactone) mats for therapeutic application. Nanomaterials, 11. · DOI
  34. Gao, 2021, Mechanical properties and drug loading rate of a polycaprolactone 5-fluorouracil controlled drug delivery system, Mater. Res. Express, 8, 095302, 10.1088/2053-1591/ac1fb5 · DOI
  35. Glover, K., Mathew, E., Pitzanti, G., Magee, E., and Lamprou, D. (2022). 3D bioprinted scaffolds for diabetic wound healing applications. Drug Deliv. Transl. Res. · DOI
  36. Rychter, 2018, Cilostazol-loaded poly(ε-caprolactone) electrospun drug delivery System for cardiovascular applications, Pharm. Res., 35, 32, 10.1007/s11095-017-2314-0 · DOI
  37. Martin, 1981, The mechanical properties of human dura mater and the effects of storage media, Clin. Phys. Physiol. Meas., 2, 197, 10.1088/0143-0815/2/3/003 · doi:10.1088/0143-0815/2/3/003
  38. Zarzur, 1996, Mechanical properties of the human lumbar dura mater, Arq. Neuropsiquiatr., 54, 455, 10.1590/S0004-282X1996000300015 · DOI
  39. Kamaraj, 2017, Fabrication, characterization, in vitro drug release and glucose uptake activity of 14-deoxy, 11, 12-didehydroandrographolide loaded polycaprolactone nanoparticles, Asian J. Pharm. Sci., 12, 353, 10.1016/j.ajps.2017.02.003 · DOI
  40. Yoo, 2020, Phenomenology of the initial burst release of drugs from PLGA microparticles, ACS Biomater. Sci. Eng., 6, 6053, 10.1021/acsbiomaterials.0c01228 · DOI · Paper page
  41. Hu, 2014, Electrospinning of polymeric nanofibers for drug delivery applications, J. Control. Release, 185, 12, 10.1016/j.jconrel.2014.04.018 · DOI · Paper page
  42. Karuppuswamy, 2015, Polycaprolactone nanofibers for the controlled release of tetracycline hydrochloride, Mater. Lett., 141, 180, 10.1016/j.matlet.2014.11.044 · DOI
  43. Liu, 2018, Polycaprolactone nanofibres loaded with 20(S)-protopanaxadiol for in vitro and in vivo anti-tumour activity study, R. Soc. Open Sci., 5, 180137, 10.1098/rsos.180137 · DOI
  44. Frantz, 1943, Absorbable Cotton, Paper and Gauze: (Oxidized Cellulose), Ann. Surg., 118, 116, 10.1097/00000658-194311810-00010 · doi:10.1097/00000658-194311810-00010
  45. Spangler, 2003, In Vitro Antimicrobial Activity of Oxidized Regenerated Cellulose against Antibiotic-Resistant Microorganisms, Surg. Infect., 4, 255, 10.1089/109629603322419599 · DOI
  46. Huang, 2001, On the importance and mechanisms of burst release in matrix-controlled drug delivery systems, J. Control. Release, 73, 121, 10.1016/S0168-3659(01)00248-6 · DOI · Paper page
  47. Page, 1993, Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care, Arch. Surg., 128, 79, 10.1001/archsurg.1993.01420130087014 · doi:10.1001/archsurg.1993.01420130087014
  48. Patel, 2019, Risk factors for surgical site infections in neurosurgery, Ann. R. Coll. Surg. Engl., 101, 220, 10.1308/rcsann.2019.0001 · doi:10.1308/rcsann.2019.0001
  49. Mindermann, 2021, Empirically adapted or personalized antibiotic prophylaxis in select cranial neurosurgery?, Acta Neurochir., 163, 365, 10.1007/s00701-020-04558-5 · doi:10.1007/s00701-020-04558-5

Cited by

See all 17

Metadata

Authors
Sanpakitwattana, A., Suvannapruk, W., Chumnanvej, S., Hemstapat, R., & Suwanprateeb, J.
Affiliations
  • Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
  • Biofunctional Materials and Devices Research Group, National Metal and Materials Technology Center (MTEC), Pathum Thani 12120, Thailand
  • Neurosurgical Unit, Surgery Department, Faculty of Medicine Ramathibodi Hospital, Bangkok 10400, Thailand
Venue
Polymers
Publisher
MDPI AG
Published
2022-10-21
Volume
14
Issue
20
Pages
4449
ISSN
2073-4360
Cited by
17
References
2
Language
en
Funders
  • Science Achievement Scholarship of Thailand
  • Faculty of Science and the Faculty of Medicine Ramathibodi Hospital, Mahidol University
  • National Metal and Materials Technology Center (MTEC)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.